Singlera Genomics Raises $60 Million in Series A+ Financing

LA JOLLA, Calif., March 27, 2018 -- (Healthcare Sales & Marketing Network) -- Singlera Genomics, a non-invasive genetic diagnostics company that focuses on early-stage cancer detection, today announced that it has successfully secured a US$60 million Seri... Diagnostics, Venture Capital Singlera Genomics, non-invasive genetic diagnosis, single cell DNA sequencing
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news